PRELUDE THERAPEUTICS INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.07 USD | +0.74% |
|
+9.41% | -4.68% |
Chart calendar Prelude Therapeutics Incorporated
da7682f89c296b5.LtRulDnw2t6iIPVqCFU_ze7_H3lJS3gM437qHhAzZBk.HqUt4UHIo7bLUJRaZBJSnKeSUx54Jy881UadantrLW9ehRTQa5Psn-sYkg~d21057224dc797b0902ffae79675d8bc
Upcoming events on Prelude Therapeutics Incorporated
Past events on Prelude Therapeutics Incorporated
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Abstract No - 5710 |
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Abstract No - 5966 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract No - 4503 |
| 2024-04-05 10:00 pm | American Association for Cancer Research Meeting |
| 2024-03-13 03:05 pm | Barclays Global Healthcare Conference - Fireside Chat |
| 2024-02-15 04:05 pm | Q4 2023 Earnings Release |
| 2023-11-01 04:10 pm | Q3 2023 Earnings Release |
| 2023-10-10 | AACR-NCI-EORTC International Conference |
| 2023-09-12 04:55 pm | Morgan Stanley Global Healthcare Conference |
| 2023-09-11 01:30 pm | H.C. Wainwright Global Investment Conference |
| 2023-09-06 04:30 pm | Wells Fargo Healthcare Conference |
| 2023-08-03 08:00 am | Q2 2023 Earnings Release |
| 2023-06-16 01:00 pm | Annual General Meeting |
| 2023-06-07 08:00 am | Jefferies Global Healthcare Conference |
| 2023-05-15 12:00 pm | JMP Securities Life Sciences Conference |
| 2023-05-10 07:20 pm | Bank of America Healthcare Conference |
| 2023-05-08 08:30 am | Q1 2023 Earnings Release |
| 2023-05-02 01:30 pm | H.C. Wainwright BioConnect Investor Conference |
| 2023-04-19 09:00 am | American Association for Cancer Research Meeting - Abstract Number: 6147 |
| 2023-04-19 09:00 am | American Association for Cancer Research Meeting - Abstract Number: 5973 |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -58,2 -58,9 1.14% | -113 -114 1.01% | -122 -119 -2.63% | -131 -131 -0.05% | -158 |
|
EBIT Million USD | Released Forecast Spread | -58,8 -59,3 0.88% | -114 -114 0.66% | -124 -120 -2.68% | -132 -131 -0.97% | -154 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -115 -120 3.64% | 0,00 0,00 - | -140 |
|
Net income Million USD | Released Forecast Spread | -56,9 -56,7 -0.49% | -112 -111 -0.2% | -115 -118 1.86% | -122 -121 -0.95% | -140 |
|
EPS USD | Released Forecast Spread | -4,56 -1,76 -159.09% | -2,43 -2,42 -0.62% | -2,44 -2,48 1.61% | -2,02 -2,02 0% | -2,03 |
| Announcement Date | 16/03/21 | 16/03/22 | 15/03/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -30,0 -30,7 2.43% | -29,1 -28,8 -1.36% | -30,1 -31,3 4.06% | |||||||||||
|
EBIT Million USD | Released Forecast Spread | -33,0 -33,9 2.59% | -30,3 -30,7 1.43% | -29,5 -30,4 3.04% | -30,4 -30,7 0.84% | -33,4 -30,4 -9.67% | -29,1 -32,4 10.04% | -32,4 -30,0 -7.99% | -33,4 -33,5 0.48% | -37,4 -34,6 -8.1% | -36,6 | -37,2 | -37,9 | -39,5 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -27,4 -30,6 10.54% | -30,0 -29,8 -0.53% | -28,6 -30,7 6.71% | -27,7 -29,9 7.3% | -30,4 -30,0 -1.44% | -30,6 -30,2 -1.35% | -33,4 | -34,1 | -34,8 | -37,6 | ||||
|
Net income Million USD | Released Forecast Spread | -32,8 -32,6 -0.69% | -29,5 -30,2 2.49% | -27,4 -29,9 8.6% | -30,0 -30,1 0.62% | -28,6 -30,1 4.73% | -27,7 -32,2 13.88% | -30,4 -30,0 -1.44% | -30,6 -30,6 0.08% | -33,1 -31,9 -3.6% | -33,3 | -34,2 | -35,1 | -37,1 | |
|
EPS USD | Released Forecast Spread | -0,71 -0,70 -2.16% | -0,63 -0,65 3.08% | -0,58 -0,59 1.14% | -0,63 -0,63 0.53% | -0,60 -0,63 4.76% | -0,58 -0,68 14.07% | -0,54 -0,63 14.29% | -0,45 -0,56 19.64% | -0,45 -0,47 4.26% | -0,50 | -0,51 | -0,52 | -0,51 | -0,46 |
| Announcement Date | 16/03/22 | 10/05/22 | 09/08/22 | 14/11/22 | 15/03/23 | 08/05/23 | 03/08/23 | 01/11/23 | 15/02/24 | - | - | - | - | - |
More events
Past sector events for Prelude Therapeutics Incorporated
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PRLD Stock
- Calendar Prelude Therapeutics Incorporated
